Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated to v3.5.0 and the previous v3.4.3 tag was removed.SummaryDifference0.1%

- Check43 days agoChange Detected- Footer revision label updated from v3.4.2 to v3.4.3. This is a metadata-only change in the footer and does not affect page content or functionality.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.SummaryDifference0.5%

- Check79 days agoChange DetectedA site-wide funding status notice was added and the revision history was updated to version v3.4.1 (removing v3.4.0).SummaryDifference0.6%

- Check87 days agoChange DetectedAdded a new 'Show glossary' option and updated the revision to v3.4.0. Capitalization changes were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.3%

Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.